| Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the pharmacokinetic parameters of 10 CYP3A substrates M Saiz-Rodríguez, S Almenara, M Navares-Gómez, D Ochoa, M Román, ... Biomedicines 8 (4), 94, 2020 | 87 | 2020 |
| Effect of ABCB1 C3435T polymorphism on pharmacokinetics of antipsychotics and antidepressants M Saiz‐Rodríguez, C Belmonte, M Román, D Ochoa, C Jiang‐Zheng, ... Basic & clinical pharmacology & toxicology 123 (4), 474-485, 2018 | 71 | 2018 |
| Effect of polymorphisms on the pharmacokinetics, pharmacodynamics and safety of sertraline in healthy volunteers M Saiz‐Rodríguez, C Belmonte, M Román, D Ochoa, D Koller, M Talegón, ... Basic & clinical pharmacology & toxicology 122 (5), 501-511, 2018 | 67 | 2018 |
| Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects M Saiz‐Rodríguez, D Ochoa, C Herrador, C Belmonte, M Román, E Alday, ... Basic & clinical pharmacology & toxicology 124 (3), 321-329, 2019 | 65 | 2019 |
| Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to … D Koller, V Vaitsekhovich, C Mba, JL Steegmann, P Zubiaur, ... Talanta 208, 120450, 2020 | 59 | 2020 |
| Differential effects of oxytocin on social sensitivity in two distinct breeds of dogs (Canis familiaris) K Kovács, A Kis, Á Pogány, D Koller, J Topál Psychoneuroendocrinology 74, 212-220, 2016 | 55 | 2016 |
| Simultaneous determination of six antipsychotics, two of their metabolites and caffeine in human plasma by LC-MS/MS using a phospholipid-removal microelution-solid phase … D Koller, P Zubiaur, M Saiz-Rodríguez, F Abad-Santos, A Wojnicz Talanta 198, 159-168, 2019 | 47 | 2019 |
| Epidemiologic and genetic associations of endometriosis with depression, anxiety, and eating disorders D Koller, GA Pathak, FR Wendt, DS Tylee, DF Levey, C Overstreet, ... JAMA network open 6 (1), e2251214-e2251214, 2023 | 45 | 2023 |
| Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics M Saiz-Rodríguez, D Ochoa, C Belmonte, M Román, D Vieira de Lara, ... Journal of Psychopharmacology 33 (4), 522-531, 2019 | 45 | 2019 |
| Utility of therapeutic drug monitoring of imatinib, nilotinib, and dasatinib in chronic myeloid leukemia: a systematic review and meta-analysis M García-Ferrer, A Wojnicz, G Mejía, D Koller, P Zubiaur, F Abad-Santos Clinical Therapeutics 41 (12), 2558-2570. e7, 2019 | 42 | 2019 |
| Dog-owner attachment is associated with oxytocin receptor gene polymorphisms in both parties. A comparative study on Austrian and Hungarian border collies K Kovács, Z Virányi, A Kis, B Turcsán, Á Hudecz, MT Marmota, D Koller, ... Frontiers in Psychology 9, 435, 2018 | 40 | 2018 |
| Genetic polymorphisms associated with the pharmacokinetics, pharmacodynamics and adverse effects of olanzapine, aripiprazole and risperidone P Soria-Chacartegui, G Villapalos-García, P Zubiaur, F Abad-Santos, ... Frontiers in Pharmacology 12, 711940, 2021 | 38 | 2021 |
| Metabolic effects of aripiprazole and olanzapine multiple-dose treatment in a randomised crossover clinical trial in healthy volunteers: association with pharmacogenetics D Koller, S Almenara, G Mejía, M Saiz-Rodríguez, P Zubiaur, M Román, ... Advances in therapy 38, 1035-1054, 2021 | 32 | 2021 |
| Influence of CYP450 enzymes, CES1, PON1, ABCB1, and P2RY12 polymorphisms on clopidogrel response in patients subjected to a percutaneous neurointervention M Saiz-Rodríguez, C Belmonte, JL Caniego, D Koller, P Zubiaur, ... Clinical Therapeutics 41 (6), 1199-1212. e2, 2019 | 30 | 2019 |
| Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole … A Wojnicz, C Belmonte, D Koller, A Ruiz-Nuño, M Román, D Ochoa, ... Journal of Pharmaceutical and Biomedical Analysis 151, 116-125, 2018 | 27 | 2018 |
| Using phenotype risk scores to enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder FR Wendt, GA Pathak, JD Deak, F De Angelis, D Koller, ... Molecular psychiatry 27 (4), 2206-2215, 2022 | 26 | 2022 |
| The effects of Aripiprazole and olanzapine on pupillary light reflex and its relationship with Pharmacogenetics in a randomized Multiple‐Dose trial D Koller, M Saiz‐Rodríguez, P Zubiaur, D Ochoa, S Almenara, M Román, ... British journal of clinical pharmacology 86 (10), 2051-2062, 2020 | 26 | 2020 |
| Oxytocin and opioid receptor gene polymorphisms associated with greeting behavior in dogs E Kubinyi, M Bence, D Koller, M Wan, E Pergel, Z Ronai, ... Frontiers in psychology 8, 1520, 2017 | 26 | 2017 |
| Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers P Zubiaur, P Soria-Chacartegui, D Koller, M Navares-Gómez, D Ochoa, ... Biomedicine & Pharmacotherapy 133, 111087, 2021 | 24 | 2021 |
| Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran P Zubiaur, M Saiz-Rodríguez, D Ochoa, M Navares-Gómez, G Mejía, ... Advances in Therapy 37 (8), 3537-3550, 2020 | 23 | 2020 |
Pablo ZubiaurPharmaMar S.A.Verified email at pharmamar.com
